- Home
- SGC vs ANGO Comparison
SGC vs ANGO Comparison
Compare SGC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- ANGO
- Stock Information
- Founded
- SGC 1920
- ANGO 1988
- Country
- SGC United States
- ANGO United States
- Employees
- SGC N/A
- ANGO N/A
- Industry
- SGC Apparel
- ANGO Medical/Dental Instruments
- Sector
- SGC Consumer Discretionary
- ANGO Health Care
- Exchange
- SGC Nasdaq
- ANGO Nasdaq
- Market Cap
- SGC 215.7M
- ANGO 400.8M
- IPO Year
- SGC N/A
- ANGO 2004
- Fundamental
- Price
- SGC $11.78
- ANGO $10.66
- Analyst Decision
- SGC Strong Buy
- ANGO Strong Buy
- Analyst Count
- SGC 3
- ANGO 3
- Target Price
- SGC $17.33
- ANGO $19.00
- AVG Volume (30 Days)
- SGC 41.6K
- ANGO 377.7K
- Earning Date
- SGC 11-05-2025
- ANGO 10-02-2025
- Dividend Yield
- SGC 4.75%
- ANGO N/A
- EPS Growth
- SGC N/A
- ANGO N/A
- EPS
- SGC 0.52
- ANGO N/A
- Revenue
- SGC $576,240,000.00
- ANGO $292,498,000.00
- Revenue This Year
- SGC $1.46
- ANGO $7.13
- Revenue Next Year
- SGC $3.32
- ANGO $6.28
- P/E Ratio
- SGC $22.59
- ANGO N/A
- Revenue Growth
- SGC 4.03
- ANGO N/A
- 52 Week Low
- SGC $9.11
- ANGO $5.83
- 52 Week High
- SGC $18.48
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- SGC 45.96
- ANGO 66.05
- Support Level
- SGC $11.60
- ANGO $10.53
- Resistance Level
- SGC $12.27
- ANGO $11.04
- Average True Range (ATR)
- SGC 0.44
- ANGO 0.30
- MACD
- SGC -0.19
- ANGO 0.03
- Stochastic Oscillator
- SGC 8.03
- ANGO 67.25
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.